Clinical trialNCT00925990CompletedPhase 2Interventional

CTS-1027 in Interferon-Naive Hepatitis C Patients

SponsorConatus Pharmaceuticals Inc.Enrollment70Hepatitis C

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study is intended to determine whether CTS-1027 either alone or in combination with ribavirin is safe and effective in Hepatitis C patients who have not previously been treated with interferon.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Erin Castelloe, MD
Conatus Pharmaceuticals Inc.
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico

Fundacion de Investigacion de Diego
Santurce, Puerto Rico

United States

University of Alabama at Birmingham
Birmingham, Alabama, United States
Kaiser Permanante
San Diego, California, United States
Medical Associates Research Group
San Diego, California, United States
Va Medical Center, San Diego
San Diego, California, United States
University of Colorado Health Science Center
Denver, Colorado, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
University of Florida
Gainsville, Florida, United States
Tulane University Health Sciences Center
New Orleans, Louisiana, United States
University of Ma Mem Med Ctr
Worchester, Massachusetts, United States
Henry Ford Medical Center-Columbus
Novi, Michigan, United States
Mn Clinical Research Center
Plymouth, Minnesota, United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
St. Louis University
St Louis, Missouri, United States
Mount Sinai School of Medicine
New York, New York, United States
University of Nc at Chapel Hill
Chapel Hill, North Carolina, United States
Duke University Health System
Durham, North Carolina, United States
Consultants of Clinical Research, Ohio Gi and Liver Institute
Cincinnati, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
Va Medical Center, Houston
Houston, Texas, United States
Vcu-Medical College of Virginia
Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CTS-1027Placebo for ribavirinRibavirin →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2009
Primary completion: 31 May 2010
Completion: 31 Jul 2010
Last update posted: 27 Mar 2012
Registered enrollment: 70
Registry id: NCT00925990

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.